| |
| |
|
| Insider
Information: |
Levitsky Hyam |
| Relationship: |
President of R&D |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
170,710 |
|
|
Indirect Shares
|
536,544 |
|
|
| Direct
Value |
$6,819 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
707,254 |
|
|
| Total
Value |
$6,819 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Antigenics Inc |
AGEN |
Director |
2009-02-27 |
15,376 |
2009-02-27 |
0 |
Premium* |
|
|
Juno Therapeutics, Inc. |
JUNO |
EVP, Research & CSO |
2017-02-07 |
131,334 |
2015-05-28 |
0 |
Premium* |
|
|
Century Therapeutics, Inc. |
IPSC |
President of R&D |
2024-03-07 |
24,000 |
2024-03-07 |
536,544 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IPSC |
Century Therapeutics, Inc... |
President of R&D |
• – – |
2024-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
24,000 |
0 |
- |
|
| IPSC |
Century Therapeutics, Inc... |
President of R&DOfficer |
• – – |
2023-04-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
536,544 |
|
- |
|
| IPSC |
Century Therapeutics, Inc... |
President of R&DOfficer |
• – – |
2021-06-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
536,544 |
|
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP, Research & CSO |
• – – |
2017-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
14,634 |
131,334 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP, Research & CSO |
• – – |
2016-06-17 |
4 |
AS |
$42.76 |
$531,081 |
D/D |
(12,418) |
116,700 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP, Research & CSO |
• – – |
2016-05-27 |
4 |
D |
$42.04 |
$691,726 |
D/D |
(16,454) |
129,118 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
See Remarks |
• – – |
2015-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
145,000 |
145,000 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Director |
– • – |
2009-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,376 |
15,376 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
